학술논문

Safety and immunogenicity of the gamtbvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled study
Document Type
Article
Source
In: Vaccines. (Vaccines, December 2020, 8(4):1-17)
Subject
Language
English
ISSN
2076393X